日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Treating Hematological Malignancies With OR-2100, an Orally Bioavailable Prodrug of Decitabine

使用口服生物利用度高的地西他滨前药 OR-2100 治疗血液系统恶性肿瘤

Watanabe, Tatsuro; Kidoguchi, Keisuke; Kimura, Shinya

Correction: A comprehensive assessment using multiple factors based on HAS-Flow analysis predicts ATL development and progression

更正:基于HAS-Flow分析的多因素综合评估可预测成人T细胞白血病/淋巴瘤(ATL)的发生发展。

Nakamura, Hideaki; Watanabe, Tatsuro; Sato, Akemi; Kawaguchi, Atsushi; Uchimaru, Kaoru; Satou, Yorifumi; Sueoka, Eisaburo

A comprehensive assessment using multiple factors based on HAS-Flow analysis predicts ATL development and progression

基于HAS-Flow分析的多因素综合评估可预测成人T细胞白血病(ATL)的发生发展。

Nakamura, Hideaki; Watanabe, Tatsuro; Sato, Akemi; Kawaguchi, Atsushi; Uchimaru, Kaoru; Satou, Yorifumi; Sueoka, Eisaburo

Targeting Oxidative Phosphorylation with a Novel Thiophene Carboxamide Increases the Efficacy of Imatinib against Leukemic Stem Cells in Chronic Myeloid Leukemia.

利用新型噻吩甲酰胺靶向氧化磷酸化可提高伊马替尼对慢性粒细胞白血病白血病干细胞的疗效

Kusaba Kana, Watanabe Tatsuro, Kidoguchi Keisuke, Yamamoto Yuta, Tomoda Ayaka, Hoshiko Toshimi, Kojima Naoto, Nakata Susumu, Kimura Shinya

Assessment of transthyretin instability in patients with wild-type transthyretin amyloid cardiomyopathy

野生型转甲状腺素蛋白淀粉样心肌病患者的转甲状腺素蛋白不稳定性评估

Takuya Iino, Manabu Nagao, Hidekazu Tanaka, Sachiko Yoshikawa, Junko Asakura, Makoto Nishimori, Masakazu Shinohara, Amane Harada, Shunsuke Watanabe, Tatsuro Ishida, Ken-Ichi Hirata, Ryuji Toh

P1233: TUMOR PREVENTION USING DNA DEMETHYLATING AGENTS ON VIRUS-DERIVED CARCINOGENESIS IN MICE

P1233:利用DNA去甲基化剂预防小鼠病毒性致癌作用

Singh, Shivendra V; Warin, Renaud; Xiao, Dong; Powolny, Anna A; Stan, Silvia D; Arlotti, Julie A; Zeng, Yan; Hahm, Eun-Ryeong; Marynowski, Stanley W; Bommareddy, Ajay; Desai, Dhimant; Amin, Shantu; Parise, Robert A; Beumer, Jan H; Chambers, William H; Yamamoto, Yuta; Watanabe, Tatsuro; Ureshino, Hiroshi; Kamachi, Kazuharu; Kurahashi, Yuki; Yamashita, Satoshi; Hattori, Naoko; Ushijima, Toshikazu; Kimura, Shinya

Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL

双重靶向异常DNA和组蛋白甲基化可协同抑制成人T细胞白血病/淋巴瘤(ATL)中的肿瘤细胞生长。

Kurahashi, Yuki; Watanabe, Tatsuro; Yamamoto, Yuta; Ureshino, Hiroshi; Kamachi, Kazuharu; Yoshida-Sakai, Nao; Fukuda-Kurahashi, Yuki; Yamashita, Satoshi; Hattori, Naoko; Nakamura, Hideaki; Kawaguchi, Atsushi; Ushijima, Toshikazu; Sueoka, Eisaburo; Kimura, Shinya

Cancer progression by the okadaic acid class of tumor promoters and endogenous protein inhibitors of PP2A, SET and CIP2A

肿瘤促进剂冈田酸类以及PP2A、SET和CIP2A内源性蛋白抑制剂促进癌症进展

Fujiki, Hirota; Sueoka, Eisaburo; Watanabe, Tatsuro; Komori, Atsumasa; Suganuma, Masami

Diffuse Large B-cell Lymphoma Involving an Abundant Infiltration of T Follicular Helper Cells

弥漫性大B细胞淋巴瘤伴大量滤泡辅助性T细胞浸润

Ishii, Keitaro; Kamachi, Kazuharu; Okamoto, Sho; Katsuya, Hiroo; Fujita, Mai; Nagaie, Toshiaki; Nishioka, Atsujiro; Yoshimura, Mariko; Ureshino, Hiroshi; Kubota, Yasushi; Ando, Toshihiko; Watanabe, Tatsuro; Takeuchi, Mai; Kai, Keita; Ohshima, Koichi; Kimura, Shinya

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer

CLIP1-LTK融合基因是非小细胞肺癌的致癌驱动基因。

Hiroki Izumi #,Shingo Matsumoto #,Jie Liu,Kosuke Tanaka,Shunta Mori,Kumiko Hayashi,Shogo Kumagai,Yuji Shibata,Takuma Hayashida,Kana Watanabe,Tatsuro Fukuhara,Takaya Ikeda,Kiyotaka Yoh,Terufumi Kato,Kazumi Nishino,Atsushi Nakamura,Ichiro Nakachi,Shoichi Kuyama,Naoki Furuya,Jun Sakakibara-Konishi,Isamu Okamoto,Kageaki Taima,Noriyuki Ebi,Haruko Daga,Akira Yamasaki,Masahiro Kodani,Hibiki Udagawa,Keisuke Kirita,Yoshitaka Zenke,Kaname Nosaki,Eri Sugiyama,Tetsuya Sakai,Tokiko Nakai,Genichiro Ishii,Seiji Niho,Atsushi Ohtsu,Susumu S Kobayashi,Koichi Goto